A high-activity UK & EU sector, led by NHS ENGLAND, most recent listing 9 months ago.
Clinical services, medical equipment, pharmaceuticals, NHS contracts, and health research.
The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the drug Abiraterone (500 mg, 90 tablets) under the provisions of § 130a Abs. 8 SGB V. This agreement will be effective from December 1, 2025, to November 30, 2027. The process will involve formal procuremen
The German Social Code allows health insurance companies and pharmaceutical companies to enter into framework discount agreements for medications covered by statutory health insurance. In accordance with the relevant legal provisions for public procurement, the DAK-Gesundheit will conduct a regular
The German health insurance fund DAK-Gesundheit is seeking suppliers for a non-exclusive discount agreement for the drug Tocilizumab (specifically pre-filled syringes and pens) under the provisions of § 130a Abs. 8 SGB V. This agreement will be effective from December 1, 2025, to November 30, 2027.
The German health insurance companies and pharmaceutical companies can enter into framework discount agreements for medications covered by statutory health insurance, as permitted by § 130a paragraph 8 of the Social Code Book V. The DAK-Gesundheit will conduct a formal procurement process for the ac
This contract opportunity involves the establishment of non-exclusive discount contracts for medicines containing the active ingredient Bexarotene, in accordance with German social law. The contracts will be valid from December 1, 2025, to November 30, 2027, and can be signed at any time during this
This is not a standard procurement procedure but an open-house model. The form used is for an open procedure only because there is no specific form for the open-house model. Contracts made under this model are not subject to procurement law due to the lack of a selection decision. AOK Bayern intends
This contract opportunity involves establishing a non-exclusive discount agreement for medications containing the active ingredient Teriparatide (ATC Code: H05AA02). The contract will be effective from December 1, 2025, to November 30, 2027, with the option for suppliers to enter into the contract a
The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a paragraph 8 of the Social Code Book V. This process will provide uniform contract conditions and acc
This contract opportunity involves establishing non-exclusive discount agreements for the medication Beclometasone/Formoterol (ATC Code: R03AK08), excluding the dosage of 100µg/6µg as a metered-dose aerosol. The agreements will be made under an Open-House model, allowing all interested pharmaceutica
The Techniker Krankenkasse (TK) aims to establish discount contracts with all suitable pharmaceutical companies for the active ingredient Abemaciclib, in accordance with § 130c Abs. 1 SGB V. This contract will be part of TK's Open House Original procedure, where individual negotiations on contract t
